Keywords: Cardium Thera, Transdel Pharma, Ketotrandel, Topica analgesic, Asset purchase
Cardium to acquire Transdel’s Ph III topical analgesic and cosmeceutical assets for up to $4 million
Article | 27 June 2011
Cardium Therapeutics (NYSE Amex: CXM) has entered into an agreement with fellow USA-based Transdel Pharmaceuticals (OTC Bulletin Board: TDLP) to ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
